Company: DAWN
Filing Date: 2025-04-11
Form Type: DEF 14A
Source: 0001140361-25-013462
Chunk: 17

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-04-11
Form: DEF 14A
Chunk 17
---
 in a manner that could be interpreted as hedging.

14

TABLE OF CONTENTS Board and Committee Meetings and Attendance Our board of directors and its committees meet regularly throughout the year, and also hold special meetings and act by written consent from time to time. During fiscal year 2024, our board of directors met ten times, the audit committee met four times, the compensation committee met five times and the nominating and corporate governance committee met four times. During fiscal year 2024, each member of our board of directors attended at least 75% of the aggregate of all meetings of our board of directors and of all meetings of committees of our board of directors on which such member served that were held during the period in which such director served. Board Attendance at Annual Stockholders’ Meeting Our policy is to invite and encourage each member of our board of directors to be present at our annual meetings of stockholders. Seven of the ten of the then-current members of our board of directors were present at our 2024 annual meeting of stockholders. Presiding Director of Non-Employee Director Meetings The non-employee directors meet in regularly scheduled executive sessions without management to promote open and honest discussion. Our chair of the board of directors, currently Mr. Nicholson, is the presiding director at these meetings. Communication with Directors Stockholders or other interested parties who wish to communicate with our board of directors, non-management members of our board of directors as a group, a committee of our board of directors or a specific member of our board of directors (including our chairperson or lead independent director, if any) may do so by letters addressed to the attention of our Secretary. All communications are reviewed by the Secretary and provided to the members of our board of directors as appropriate. Unsolicited items, sales materials, abusive, threatening or otherwise inappropriate materials and other routine items and items unrelated to the duties and responsibilities of our board of directors will not be provided to directors. The address for these communications is: Day One Biopharmaceuticals, Inc. c/o Secretary 1800 Sierra Point Parkway Suite 200 Brisbane, California 94005 Code of Business Conduct and Ethics Our board of directors has adopted a written, comprehensive Code of Business Conduct and Ethics that applies to all of the members of our board of directors, officers, employees, consultants and contractors. All such individuals are trained in and affirm compliance with our comprehensive Code of Business Conduct and Ethics. Our Code of Business Conduct and Ethics is available without charge on our website, located at https://ir.dayonebio